A phase II trial of topotecan and ifosfamide in patients with previously treated, advanced non small cell lung carcinoma (NSCLC)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7314-7314
Author(s):  
V. Gebbia ◽  
M. Spada ◽  
G. Cassano ◽  
C. Brunetti ◽  
D. Germano ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Trial ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma ◽  
Previously Treated

scholarly journals Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA

2019 ◽  
Vol 10 (3) ◽  
pp. 452-458 ◽  
Author(s):  
Shinnosuke Takemoto ◽  
Yoichi Nakamura ◽  
Hiroshi Gyoutoku ◽  
Hiroaki Senju ◽  
Daiki Ogawara ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Messenger Rna ◽  
Phase Ii Trial ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma
Sign in / Sign up

Export Citation Format

Share Document